Senior insider sale
SVP, Comm & Medical Affairs at THERAVANCE BIOPHARMA, INC. — senior position signals high conviction
$651.8K
44.38K shares
What this filing means
FARNUM RHONDA plans to sell 44.38K shares of THERAVANCE BIOPHARMA, INC. valued at approximately $651.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/15/2026ACC: 0001950047-26-006154
Officer· SVP, Comm & Medical Affairs
Since Dec 2021
44.38K
Shares to sell
$651.8K
Approx. market value
13.31K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock
Not Applicable
8/20/2023
13.31KTotal acquired13.31K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/20/2023 | Restricted Stock Not Applicable | 13.31K | — |
| Total | 13.31K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
31.07K
Market value
$433.6K
3/16/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
13.31K
Market value
$218.2K
6/15/2026
Total
Units
44.38K
Value
$651.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/16/2026 | 31.07K | $433.6K | — | Completed |
| Planned — Approximate Date | ||||
6/15/2026 | 13.31K | $218.2K | NASDAQ | Planned |
| Total | 44.38K | $651.8K | ||